Mutational analysis of 105 mucopolysaccharidosis type VI patients.
about
Attenuated osteoarticular phenotype of type VI mucopolysaccharidosis: a report of four patients and a review of the literatureMucopolysaccharidosis VI.Segregation analysis in a family at risk for the Maroteaux-Lamy syndrome conclusively reveals c.1151G>A (p.S384N) as to be a polymorphism.Molecular testing of 163 patients with Morquio A (Mucopolysaccharidosis IVA) identifies 39 novel GALNS mutationsMolecular Analysis of Turkish Maroteaux-Lamy Patients and Identification of One Novel Mutation in the Arylsulfatase B (ARSB) GeneMucopolysaccharidosis I, II, and VI: Brief review and guidelines for treatment.Illness perception and clinical treatment experiences in patients with M. Maroteaux-Lamy (mucopolysaccharidosis type VI) and a Turkish migration background in Germany.Growth Charts for Individuals with Mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome)Prevalence of anti-adeno-associated virus serotype 8 neutralizing antibodies and arylsulfatase B cross-reactive immunologic material in mucopolysaccharidosis VI patient candidates for a gene therapy trial.Glycosaminoglycan storage disorders: a reviewCardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and managementMedical genetics and genomic medicine in India: current status and opportunities ahead.Mucopolysaccharidosis VI in cats - clarification regarding genetic testingMucopolysaccharidosis type VI in a Miniature Poodle-type dog caused by a deletion in the arylsulphatase B gene.Diagnostic and treatment strategies in mucopolysaccharidosis VI.Novel mutations of the arylsulphatase B (ARSB) gene in Indian patients with mucopolysaccharidosis type VI.Molecular findings of Colombian patients with type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome).Mutations in ARSB in MPS VI patients in India.Long-term cognitive follow-up in children treated for Maroteaux-Lamy syndrome.Mucopolysaccharidosis type VI phenotypes-genotypes and antibody response to galsulfase.The mucopolysaccharidoses: a success of molecular medicine.Spondyloepiphyseal dysplasias and bilateral legg-calvé-perthes disease: diagnostic considerations for mucopolysaccharidosesHaploidentical stem cell transplantation in two children with mucopolysaccharidosis VI: clinical and biochemical outcome.The constellation of skeletal deformities in a family with mixed types of mucopolysaccharidoses: Case report.Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing.Diagnosis of the mucopolysaccharidoses.Epidemiology of mucopolysaccharidoses.Molecular characterization of 355 mucopolysaccharidosis patients reveals 104 novel mutations.Mucopolysaccharidosis type I, II and VI and response to enzyme replacement therapy: Results from a single-center case series study.Dried blood spots allow targeted screening to diagnose mucopolysaccharidosis and mucolipidosis.Brain magnetic resonance imaging findings in patients with mucopolysaccharidosis VI.MPS VI - Maroteaux-Lamy syndromeOral manifestations of 17 patients affected with mucopolysaccharidosis type VI.Design, baseline characteristics, and early findings of the MPS VI (mucopolysaccharidosis VI) Clinical Surveillance Program (CSP).Mucopolysaccharidosis Type VI in a Great Dane Caused by a Nonsense Mutation in the ARSB Gene.The clinical and genetic Spectrum of Maroteaux-Lamy syndrome (Mucopolysaccharidosis VI) in the Eastern Province of Saudi Arabia.Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series.Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome)--10-year follow-up of patients who previously participated in an MPS VI Survey Study.
P2860
Q26830003-2184AEE9-B909-4E2E-9947-743993DC7A04Q33863356-46162B05-5E67-413E-88C4-00C0C1F88955Q34327046-8D78A803-54B7-44A7-ACD8-938C072ED128Q34373560-2713E948-DA48-46A8-AB23-0364902B3E52Q34422329-ACF87355-30F3-4B55-957C-0D30FBBE621EQ34562817-5BE70537-D94D-4C44-AE65-F47186A42A41Q34796031-796AA84C-51B6-4318-9E1D-CDA3C73198FCQ35183098-4DA17AD5-26E4-40ED-9E25-B05E36B377A4Q35199296-B4AB6FCB-8D4C-4C3A-98EA-2868F43132E2Q35367599-A25141EE-1F31-45F7-984D-84E60225B39CQ35587435-DE19D02D-59F8-4139-A02E-A79F60C2D217Q35648046-DC4D80F3-58EF-4E46-A291-4D7202948E37Q36066425-46F4E4B7-2C53-456C-B05A-559188BDCA12Q36108146-7146AD32-0C82-4763-B5B9-367CDDAC0112Q36253221-7429D2A7-702F-42B1-B58D-67AA28FC8640Q36383660-96492910-8E42-4148-B6FF-043C169310F7Q36521405-68A1F773-8FFC-4FE9-8388-2CF65C0A0346Q36571593-FB7C4966-9A9F-41EC-8627-85BD22E2BAA7Q36582221-B598E585-A766-4E14-8279-3DAA297DAD87Q36797802-D2C3393C-3F2E-4C5D-B367-E5A9A9ADABA1Q37059193-7D00901F-B5E0-4DC1-8CEA-B454508C7801Q37127617-86559440-762A-48A2-8428-34F11E851C08Q37154973-B388FDEF-E16C-4B2A-8F89-D5931A4A98A8Q37176061-9BFE67D2-F8F0-402C-B5B1-4D046ED1355AQ37615837-573615D7-60D2-455D-9E00-BDDF610BD815Q37972590-F54EBEBB-7189-4C49-B144-AC95ADF122C3Q38735623-DC18700F-E03F-4138-9FD6-8A481DCC1E6BQ39552940-5FC880FC-1BDF-496C-A4B7-052B632750CDQ41700161-12431F2A-FC62-4A26-B88F-C9F885E53C00Q43071668-DA45BF49-8890-48D4-B1D4-67BF6769127DQ43635586-BE00409D-F54E-48BA-BC8D-23DC0F72F6DEQ45316411-A07B31BA-4853-4D5C-BAEB-80A11E60133EQ45909286-EEDAC9A7-27A7-458B-9AF8-A94DE55EED08Q46869287-9848AA59-55DE-448D-B934-368AA710938EQ47705730-1D4ACD65-72C9-4FE2-8C55-73DF324ECC7DQ47979580-59EBD69A-4C25-403A-BB3A-249EC294F587Q47990521-9951B25D-43D9-4101-8F33-E56857CCBD13Q52902721-83B40A13-DD21-434B-8276-BCA71AD2F99D
P2860
Mutational analysis of 105 mucopolysaccharidosis type VI patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Mutational analysis of 105 mucopolysaccharidosis type VI patients.
@en
Mutational analysis of 105 mucopolysaccharidosis type VI patients.
@nl
type
label
Mutational analysis of 105 mucopolysaccharidosis type VI patients.
@en
Mutational analysis of 105 mucopolysaccharidosis type VI patients.
@nl
prefLabel
Mutational analysis of 105 mucopolysaccharidosis type VI patients.
@en
Mutational analysis of 105 mucopolysaccharidosis type VI patients.
@nl
P2093
P356
P1433
P1476
Mutational analysis of 105 mucopolysaccharidosis type VI patients.
@en
P2093
Anthony Pollard
David Ketteridge
Doug A Brooks
Elisa Leão Teles
Elizabeth L Melville
James E Wraith
John J Hopwood
Leanne K Hein
Litsa Karageorgos
M Clara Sá Miranda
P304
P356
10.1002/HUMU.20534
P577
2007-09-01T00:00:00Z